Results 41 to 50 of about 101,142 (261)

Sclerosing cholangitis

open access: yesCurrent Opinion in Gastroenterology, 2003
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by strictures and dilatations of the biliary tree. The median survival has been reported to be 12 years from diagnosis but patients diagnosed during the last decade have been shown to have longer survival of a median of 18 years.
Björnsson, E, Chapman, R
openaire   +2 more sources

Short-term Results of Kasai Operation for Biliary Atresia: Experience from One Institution

open access: yesAsian Journal of Surgery, 2006
The purpose of this study is to review the short-term outcome of patients with biliary atresia (BA) treated by the Kasai operation at our institution. Methods: Ninety-two BA patients treated by the Kasai operation between January 1996 and December 2002 ...
Paiboon Sookpotarom   +4 more
doaj   +1 more source

Hepatic Abscess following Yttrium-90 Radioembolization in Patients with Surgical Bilioenteric Anastomosis or Compromised Sphincter of Oddi: A Tertiary Cancer Center Experience

open access: yesCurrent Oncology, 2022
Purpose: We describe our experience with the development of hepatobiliary infection in patients with prior surgical, percutaneous, or endoscopic biliary interventions who are receiving transarterial radioembolization (TARE) with yttrium-90 (90Y) for ...
Kevin N. Agahi   +2 more
doaj   +1 more source

Intrahepatic Cholangiocarcinoma Arising from Biliary Hamartomas in Patients with Recurrent Acute Cholangitis: A Case Report and Literature Review

open access: yesThe Korean Journal of Gastroenterology, 2023
Biliary hamartomas are tumor-like malformations of the liver. Biliary hamartomas are a type of fibrocystic disorder originating from ductal plate malformation and are typically considered benign, but with the risk of malignant transformation.
Sang Min Lee   +4 more
doaj   +1 more source

Autoimmune cholangitis. [PDF]

open access: yesGut, 1997
Autoimmune cholangitis is the term that has been used to describe patients who have the clinical, biochemical, and histologic characteristics of primary biliary cirrhosis (PBC), but who are antinuclear antibody positive rather than anti-mitochondrial antibody (AMA) positive in their sera.
openaire   +3 more sources

Drug therapy of primary biliary diseases: classical and modern strategies

open access: yes, 2013
Definition: Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are both cholestatic liver diseases. A common feature of these disorders is the accumulation of bile acids in the liver and blood, presumably because of decreased ...
Leuschner, Ulrich, Schlichting, Julia
core   +1 more source

Bacterial cholangitis causing secondary sclerosing cholangitis: a case report [PDF]

open access: yes, 2002
BACKGROUND: Although bacterial cholangitis is frequently mentioned as a cause of secondary sclerosing cholangitis, it appears to be extremely rare, with only one documented case ever reported.
ter Borg, PCJ (Pieter)   +8 more
core   +1 more source

Current understanding of primary biliary cholangitis

open access: yesClinical and Molecular Hepatology, 2020
Primary biliary cholangitis (PBC) causes chronic and persistent cholestasis in the liver, eventually resulting in cirrhosis and hepatic failure without appropriate treatment.
A. Tanaka
semanticscholar   +1 more source

Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

open access: yesAlimentary Pharmacology and Therapeutics, 2021
Obeticholic acid (OCA) and fibrates are second‐line therapies for patients with primary biliary cholangitis (PBC) with an inadequate response to ursodeoxycholic acid (UDCA).
P. Soret   +27 more
semanticscholar   +1 more source

IgG4-Related Sclerosing Cholangitis in Europe

open access: yes, 2018
IgG4-Related sclerosing cholangitis in ...
Giulia De Marchi   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy